withings

Withings

Company Overview

Withings

Company Overview

Withings is a French consumer electronics company headquartered in Issy-les-Moulineaux, France, that designs and manufactures connected health devices and smart home health solutions. Founded in 2008 by CEO Eric Carreel, Withings has established itself as a leader in the connected health device market, with a focus on medical-grade consumer devices that bridge the gap between clinical accuracy and user-friendly design["@withings"]. The company operates as a subsidiary of Nokia Corporation following Nokia's acquisition of Withings in 2016, though it maintains its brand identity and operational independence.

| Attribute | Details |
|-----------|---------|
| Founded | 2008 |
| Headquarters | Issy-les-Moulineaux, France |
| Parent Company | Nokia (acquired 2016) |
| CEO | Eric Carreel |
| Employees | ~250 |
| Stock | Private |
| Website | [withings.com](https://www.withings.com) |

Corporate History and Development

Founding and Early Growth

Withings was founded by Eric Carreel, a serial entrepreneur with a vision for connected health devices that could help individuals monitor their health parameters in everyday settings. The company's early products included the Withings Smart Body Analyzer and connected scales, which established the brand's reputation for combining elegant industrial design with accurate health measurements. The company's name is a portmanteau of "with" and "things," reflecting its mission to connect everyday objects to the internet for health monitoring purposes.

Nokia Acquisition

In 2016, Nokia Corporation acquired Withings for approximately $192 million, recognizing the strategic importance of connected health devices in the emerging digital health market. Following the acquisition, Withings became part of Nokia's broader digital health strategy, though it retained its brand identity and continued developing consumer health devices under the Withings name. This acquisition positioned Withings within Nokia's ecosystem of connected devices while maintaining access to Nokia's distribution networks and technical resources.

Product Portfolio

Withings manufactures a comprehensive portfolio of connected health devices spanning multiple health monitoring categories[@withingsa].

Body Composition Monitoring

Withings Body Scan

The Withings Body Scan represents the company's most advanced body composition analyzer, incorporating multiple sensors for comprehensive metabolic monitoring[@withingsc]. Key features include:

• Bioelectrical Impedance Analysis (BIA): Measures body composition including body fat percentage, muscle mass, and water content
• Segmental Analysis: Provides body composition data for specific body regions (arms, legs, torso)
• Heart Rate Monitoring: Integrated sensors detect heart rate during measurement
• ECG Capability: FDA-cleared electrocardiogram functionality for atrial fibrillation detection
• Arterial Stiffness: Measures pulse wave velocity as an indicator of cardiovascular health

Withings Body Med业内 Scale

The Withings Body Med业内 Scale represents the company's clinical-grade weighing solution designed for healthcare professional environments[@withingse]. This device maintains the consumer-friendly interface of Withings' consumer products while meeting medical device accuracy standards required for clinical use, supporting weight monitoring in patients with neurodegenerative diseases where weight loss and malnutrition are common complications.

Sleep Monitoring Technology

Withings Sleep Analyzer

The Withings Sleep Analyzer is a mattress-embedded sensor that provides comprehensive sleep tracking without requiring the user to wear any devices[@withingsd]. Key capabilities include:

• Sleep Cycle Analysis: Detects light, deep, and REM sleep stages using ballistocardiography
• Respiratory Monitoring: Detects sleep-disordered breathing events including apnea episodes
• Heart Rate Variability: Measures HRV as an indicator of autonomic nervous system function
• Snoring Detection: Identifies and quantifies snoring events
• Sleep Duration Tracking: Monitors total sleep time, time to sleep, and wake episodes

Cardiovascular Monitoring

Withings ScanWatch

The Withings ScanWatch combines traditional watch design with medical-grade health monitoring capabilities:

• ECG Recording: FDA-cleared electrocardiogram for atrial fibrillation detection
• SpO2 Monitoring: Blood oxygen saturation measurement
• Heart Rate Tracking: Continuous heart rate monitoring with arrhythmia detection
• Activity Tracking: Step counting, workout detection, and movement analysis
• Sleep Tracking: Integrated sleep stage analysis

Connected Scales and Health Hubs

Withings Body

The Withings Body line of connected scales provides:

• Weight measurement with high-precision sensors
• Body composition analysis (body fat percentage, muscle mass)
• Automatic synchronization with the Withings Health Mate app
• Multi-user detection and tracking
• Pregnancy mode and baby weighing functionality

Withings Thermo

The Withings Thermo is a smart temporal artery thermometer that provides:

• Quick temperature measurement with 16 infrared sensors
• Automatic temperature tracking with date-stamped readings
• Fever alert notifications
• Integration with health tracking platforms

Application in Neurodegenerative Diseases

Parkinson's Disease

Withings devices offer several potential applications in Parkinson's disease monitoring and management[@berke2021][@sigcha2020]:

Movement Analysis

Wearable devices like ScanWatch can continuously monitor movement patterns, potentially detecting:

• Tremor characteristics including frequency, amplitude, and timing
• Gait abnormalities including shuffling, freezing of gait, and falls
• Bradykinesia through reduced movement frequency and amplitude
• Movement variability that may correlate with medication status[@godinho2016][@arslan2020]

Withings devices with accelerometer sensors can detect falls, which are a significant concern in Parkinson's disease:

• Automatic fall detection algorithms
• Alert notifications to designated contacts
• Fall frequency tracking for clinical assessment
• Correlation with disease progression and medication status[@eriksson2019]

Continuous activity tracking provides insights into:

• Daily movement patterns and activity levels
• Exercise adherence and rehabilitation compliance
• Sedentary behavior and physical deconditioning
• Seasonal variation in activity levels

Alzheimer's Disease and Related Dementias

Sleep Monitoring Applications

Sleep disorders are extremely common in Alzheimer's disease and often precede cognitive decline by years[@schendan2019]. Withings Sleep Analyzer can monitor:

• Sleep architecture disruption including reduced slow-wave sleep
• Sleep fragmentation and frequent nighttime awakenings
• Circadian rhythm disturbances
• REM sleep behavior disorder (RBD), which may be a prodromal marker

Changes in daily activity patterns often accompany cognitive decline:

• Reduced physical activity and increased sedentary time
• Circadian rhythm disturbances
• Wandering behavior patterns
• Reduced engagement in daily activities

Malnutrition and weight loss are common complications in dementia:

• Regular weight tracking to detect progressive weight loss
• Body composition changes indicating muscle wasting (sarcopenia)
• Monitoring nutritional status in home-based care settings

Sleep Disorders and Neurodegeneration

The connection between sleep disorders and neurodegenerative diseases represents one of the most important frontiers in research[@delaune2020][@postuma2016]. Withings' sleep monitoring technology provides:

Longitudinal Sleep Data

• Nightly sleep quality metrics over extended periods
• Detection of sleep pattern changes that may indicate disease progression
• Correlation between sleep quality and cognitive or motor symptoms

• REM Sleep Behavior Disorder (RBD): Often a prodromal marker of synucleinopathies including Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies. Withings Sleep Analyzer can detect movements during sleep that may indicate RBD.
• Obstructive Sleep Apnea (OSA): Highly prevalent in neurodegenerative diseases and may accelerate disease progression through intermittent hypoxia and cardiovascular stress.
• Insomnia: Primary insomnia and insomnia secondary to neurodegenerative disease can be monitored longitudinally.

Withings devices have been used in research studies investigating:

• Sleep-dependent clearance of neurotoxic proteins including amyloid-beta and alpha-synuclein
• Circadian rhythm alterations in neurodegenerative diseases
• Correlation between sleep metrics and disease biomarkers
• Effects of therapeutic interventions on sleep parameters

Clinical Research Applications

Withings devices have been deployed in clinical research settings for neurodegenerative disease studies:

Clinical Trial Endpoints

• Digital biomarkers for clinical trial outcome measures
• Continuous monitoring between clinic visits
• Real-world evidence generation
• Patient-reported outcome measures through app-based questionnaires

• Home-based monitoring reducing clinic visit frequency
• Continuous data collection for disease progression assessment
• Medication response monitoring through symptom tracking
• Caregiver burden reduction through automated monitoring

• Population-based studies investigating prodromal markers
• Longitudinal studies tracking disease progression
• Cross-sectional studies comparing patient populations
• Biomarker validation studies

Technology Platform

Withings Health Mate Application

The Withings Health Mate application serves as the central platform for data aggregation and analysis:

• Data Synchronization: Automatic data synchronization from all Withings devices
• Trend Analysis: Historical data visualization and trend identification
• Integration Capabilities: Connects with Apple Health, Google Fit, and other platforms
• Healthcare Provider Features: Professional dashboard for clinical users
• Research Data Export: Capabilities for research data sharing

API and Integration Platform

Withings provides API access for healthcare provider integration:

• FHIR Integration: Healthcare data interoperability standards
• EHR Integration: Electronic health record system connections
• Clinical Decision Support: Integration with clinical workflows
• Research Platforms: Data export for research purposes

Data Security and Privacy

Withings maintains data security through:

• End-to-end encryption for data transmission
• Secure cloud storage with industry-standard protocols
• GDPR compliance for European users
• HIPAA-compliant options for healthcare applications

Competitive Landscape

Withings operates in the connected health device market with several competitive dynamics[@withingsa]:

| Competitor | Primary Focus | Key Products |
|------------|---------------|---------------|
| Apple | Consumer wearables, health integration | Apple Watch, iPhone Health |
| Samsung | Smartwatches, health ecosystem | Galaxy Watch, Samsung Health |
| Oura | Sleep and recovery tracking | Oura Ring |
| Whoop | Fitness and recovery monitoring | Whoop 4.0 |
| Fitbit (Google) | Consumer fitness, health tracking | Fitbit Sense, Charge |
| Garmin | Fitness and outdoor wearables | Fenix, Vivo series |

Competitive Differentiation

Withings differentiates through several strategic factors:

Clinical Validation and Research

Regulatory Clearances

Withings has obtained regulatory clearances for several medical device features:

• FDA Clearance: ScanWatch ECG functionality, Body Scan features
• CE Marking: European medical device certification for clinical-grade features
• Medical Device ISO Certification: ISO 13485 quality management systems for medical devices

Published Research

Withings devices have been used in various published research studies:

• Validation studies for weight and body composition measurement accuracy
• Sleep monitoring validation against polysomnography
• Cardiovascular parameter accuracy studies
• Consumer health device utility in chronic disease management

Future Directions and Strategic Outlook

Product Development Roadmap

Withings has indicated several areas of potential expansion relevant to neurodegenerative diseases:

Market Opportunity

The intersection of connected health devices and neurodegenerative disease represents a significant market opportunity:

• Aging Population: Global demographic shifts increase prevalence of Alzheimer's disease and Parkinson's disease
• Remote Monitoring Demand: COVID-19 accelerated adoption of remote patient monitoring
• Digital Therapeutics Growth: Integration of monitoring devices with digital therapeutic platforms
• Value-Based Care: Healthcare system transition to value-based care models emphasizing outcomes over volume

Strategic Partnerships

Potential strategic directions include:

• Healthcare System Partnerships: Integration with healthcare delivery organizations for chronic disease management
• Pharmaceutical Collaboration: Partnership with pharmaceutical companies for clinical trial endpoints and patient monitoring
• Research Institution Collaboration: Academic partnerships for digital biomarker validation
• Payer Integration: Collaboration with health insurance companies for covered device programs

Regulatory and Reimbursement Considerations

Regulatory Landscape

Connected health devices for neurodegenerative disease monitoring face evolving regulatory requirements:

• FDA Digital Health Initiatives: Ongoing FDA guidance development for digital health devices
• Software as Medical Device (SaMD): Regulatory frameworks for software-based medical devices
• Cybersecurity Requirements: Increasing cybersecurity requirements for connected medical devices

Reimbursement Pathways

Current reimbursement landscape for connected health devices:

• Traditional Medicare: Limited coverage for consumer health devices
• Medicare Advantage: Some coverage through Medicare Advantage plans
• Private Insurance: Variable coverage depending on specific device and indication
• Direct-to-Consumer: Primary business model with consumer out-of-pocket payment

Implementation Considerations

For Healthcare Providers

Healthcare systems considering Withings integration should evaluate:

For Patients and Caregivers

Patients and caregivers implementing Withings devices should consider:

Cross-Links

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Sleep Disorders in Neurodegeneration](/mechanisms/sleep-neurodegeneration-connection)
• [Digital Biomarkers](/mechanisms/digital-biomarkers-parkinsons-disease)
• [Wearable Technologies for Parkinson's Disease](/companies/wearable-technologies-parkinsons-disease)
• [Remote Patient Monitoring](/mechanisms/remote-patient-monitoring-neurodegeneration)

References